MHLW Advisory Committee to Review Biogen’s MS Drug on Nov. 25

A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss on November 25 whether to recommend a batch of five drugs for approval, including Biogen Japan’s multiple sclerosis (MS) drug dimethyl fumarate, known as Tecfidera...read more